The British Society for Antimicrobial Chemotherapy (BSAC) is delighted to announce a new partnership with Pfizer, focussing on the development of centres of excellence for Antimicrobial Stewardship (AMS) practice, with the goal of reducing inequities in access to AMS programmes and improving patient outcomes.

The landmark Global Research on Antimicrobial Resistance (GRAM) report, which was published in The Lancet today, will ring alarm bells at the highest levels of government, health leaders and policymakers around the world. The report, which reviews data from 204 countries and territories, gives the best estimate yet of the scale of antimicrobial resistance (AMR) globally.

To celebrate our 50th anniversary, we’re inviting a select number of experts to share what they see as being the 21st-century solutions to one of the biggest and most complex challenges of our generation: antimicrobial resistance (AMR). In this post, Dr Alix Brazier, Sarah Merriam and David Halpern, of the UK’s Behavioural Insights Team (BIT), explore how applying behavioural science can impact AMR…

It is with regret that we inform you that the above event has been switched to a virtual-only event. This is in light of pending UK Government Cabinet discussions today regarding potential for implementation of Plan B as early as tomorrow.

To celebrate our 50th anniversary, we’re inviting a select number of experts to share what they see as being the 21st-century solutions to one of the biggest and most complex challenges of our generation: antimicrobial resistance. In this post, Esmita Charani explores why culture matters in antibiotic resistance…

York Trials Unit (University of York), in collaboration with Hull University Teaching Hospitals NHS Trust and Hull York Medical School, are calling for expressions of interest from hospitals around the UK to take place in the BioDriveAFS trial. This research is funded by the National Institute for Health Research.

Following the publication of both the English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) report 2020-2021 and its Scottish equivalent, Scottish One Health Antimicrobial Use and Antimicrobial Resistance in 2020, it might be tempting to celebrate the reported fall in the number of deaths in England attributable to antibiotic-resistance (AMR), as well as the overall decline in antibiotic consumption across England and Scotland. Yet we must remember that the ongoing COVID-19 pandemic will have, in all likelihood, distorted the picture.

To celebrate our 50th anniversary, we’re inviting a select number of experts to share what they see as being the 21st-century solutions to one of the biggest and most complex challenges of our generation: antimicrobial resistance. In this post, Dilip Nathwani explores the future of healthcare workers and antimicrobial stewardship...